“…Several other genes (SVEP1, COL8A1, LTBP2, SLO, SERPINF1, PDGFD, BMP4, LMO4, SFRP2 and SLC26A2), found to be downregulated in high-grade meningiomas in this study, have been previously reported with reduced expression in high-grade meningiomas (13). The inhibition of expression of some of these genes has been shown to be involved in tumorigenesis; this has been demonstrated for SLO in osteosarcoma (44), for SERPINF1 in breast cancer (45) and non-small cell lung cancer (46) and for LMO4 in several tumour types, including breast, prostate and pancreatic ductal adenocarcinomas (47). Furthermore, the frequent presence of ADAMTSL3 mutations has been reported in colorectal cancer (48) and decreased ADAMTSL3 mRNA expression, as observed in colorectal malignancy (48), may contribute to the progression of meningiomas.…”